Sort
82,697 grants matching “vaccine development”
FLSC - Vaccine Branch HIV Vaccine Primate Study
$2,505,345Mary Custer · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HIV/SIV Data Base and Analysis Unit
$2,504,900Bette Korber · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
Cancer Center Support Grant
$2,502,881George J Weiner · University Of Iowa · P30 · FY2021 · CA
Cancer Center Support Grant
$2,502,881Mark E Burkard · University Of Iowa · P30 · FY2024 · CA
Cancer Center Support Grant
$2,502,881Mark E Burkard · University Of Iowa · P30 · FY2025 · CA
Cancer Center Support Grant
$2,502,881George J Weiner · University Of Iowa · P30 · FY2022 · CA
Cancer Center Support Grant
$2,502,881Michael D. Henry · University Of Iowa · P30 · FY2023 · CA
Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness
$2,501,503Farhang Alem · George Mason University · UC7 · FY2025 · AI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component C: Clinical Core
$2,501,263Chip Walter · Duke University · N01 · FY2024 · AI
Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice
$2,500,944Todd M Allen · Massachusetts General Hospital · P01 · FY2013 · AI
Center for Statistics and Quantitative Infectious Diseases
$2,500,411M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2017 · GM
Center for Statistics and Quantitative Infectious Diseases
$2,500,411M Elizabeth Halloran · Fred Hutchinson Cancer Research Center · U54 · FY2016 · GM
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
$2,500,001Judith S. Currier · University Of California Los Angeles · UM1 · FY2023 · AI
City of Hope Lymphoma SPORE
$2,500,000Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2018 · CA
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
$2,500,000Myron Max Levine · University Of Maryland Baltimore · U19 · FY2019 · AI
SPORE in Gastrointestinal Cancers
$2,500,000Alison P Klein · Johns Hopkins University · P50 · FY2018 · CA
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
$2,500,000Myron Max Levine · University Of Maryland Baltimore · U19 · FY2023 · AI
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
$2,500,000Myron Max Levine · University Of Maryland Baltimore · U19 · FY2021 · AI
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
$2,500,000Myron Max Levine · University Of Maryland Baltimore · U19 · FY2022 · AI
SPORE in Cervical Cancer
$2,500,000Johns Hopkins University · P50 · FY2003 · CA
Surveillance for Respiratory Syncytial Virus (RSV) and Other Viral Respiratory Infections Among American Indians/Alaska Natives
$2,500,000Laura Hammitt · Johns Hopkins University · U01 · FY2023 · IP
Active Vaccination and Passive Antibody Strategies to Prevent Disease Caused by Multidrug-Resistant Bacterial Pathogens
$2,500,000Myron Max Levine · University Of Maryland Baltimore · U19 · FY2020 · AI
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
$2,500,000Vel Murugan · Arizona State University-Tempe Campus · U01 · FY2022 · IP
University of Puerto Rico Clinical Trials Unit
$2,499,265Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2013 · AI
Third Coast Center for AIDS Research
$2,498,643Brian Mustanski · Northwestern University At Chicago · P30 · FY2025 · AI